June | 2024

logo image


Cataracts and Cataract Surgery

a senior wearing glasses

Prevent Blindness has designated June as Cataract Awareness Month.

Cataract is the leading cause of blindness worldwide and the leading cause of vision loss in the United States. Additionally, an estimated 20.5 million Americans aged 40 years and older have cataract in one or both eyes. More than half of all Americans have cataracts by the time they are 80 years old. However, cataract can also sometimes be found in young people or even newborn babies (congenital).

Learn More

Cataract Resources at Prevent Blindness


A Guide to Cataract Surgery

Vision Care Financial Assistance

Focus on Eye Health Expert Series: Understanding Cataract

"It Started With an Eye Exam"

Prevent Blindness is launching a new campaign, “It Started With an Eye Exam,” to encourage consumers to share their stories of how eye care had a positive impact on their health and wellbeing.

"It Started With an Eye Exam" Tasha says she knew she was at risk for glaucoma, but it wasn't until she got a dilated eye exam that she knew for sure.

The goal of the new program is to increase awareness about the role that vision health plays in overall health, demonstrate the dramatic impact that improved vision can have on productivity and quality of life, and to educate the general public about steps they can take to prepare for an eye examination. The “It Started With an Eye Exam” program is supported by funding from Viatris Inc., a global healthcare company.

Find out More

New Resources for Stargardt Disease

Stargardt disease, also called Stargardt macular dystrophy, causes vision loss due to a buildup of fatty material in the macula. The macula is a small area in the center of the retina that is responsible for sharp, straight-ahead vision. Stargardt disease is a rare eye genetic disease – part of a group of conditions called inherited retinal diseases (or IRDs), generally caused by a variation in one or more genes, causing the gene to not work properly. Stargardt disease affects about 1 in 10,000 people in the United States.

Prevent Blindness has created new educational materials on Stargardt disease, a form of inherited retinal disease (IRD). Prevent Blindness now offers a dedicated webpage, fact sheets, a new Focus on Eye Health Expert Series episode, and social media graphics. The effort is supported by funding from Alkeus Pharmaceuticals, Inc.

an image showing simulated vision loss from Stargardt disease

Inherited Retinal Diseases and Genetic Testing

Identifying the genetic cause of disease is an important part of care for patients with Inherited Retinal Diseases (IRDs). Many times, the exact type of IRD a person has can be difficult to determine based only on tests conducted in the eye doctor’s office. Results from genetic testing can lead to an accurate diagnosis if there is a positive finding. 

Find out More

How to Take Eye Drops

a glaucoma patient putting eye drops in his eyes

Eye drops are used to treat many different eye conditions, including dry eyes, allergies, and glaucoma. A new Prevent Blindness video and online guide offer simple steps and tips for putting drops in your eyes to help you prevent infection and get more of the medicine into your eyes where it can do its work.

Watch the Video
Read the Guide

Join Us for the Focus on Eye Health Summit!

13tgh Annual Focus on Eye Health Summit, July 10-11, 2024, Being Seen and Heard

Prevent Blindness will host the 13th annual Focus on Eye Health Summit on July 10-11, 2024, as a FREE virtual interactive event. This year’s theme – “Being Seen and Heard” – emphasizes the importance of a person-centered approach to vision health interventions, research, communications, and care.


DAY 1:

  • Keynote Presentation: The Patient Voice & Reaction Panel 
  • Vision Research and the Citizen Scientist
  • Presentation of the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health
  • Seeing and Hearing Children's Vision Needs
  • Presentation of the 2024 Rising Visionary Award

DAY 2:

  • Keynote Fireside Chat: The Human Side of AI in Healthcare
  • The Many Eyes in Artificial Intelligence
  • Visible Voices: Vignettes of Being Seen and Heard
Register Today!
Pathway to Diagnosis: Genetic Testing for Inherited Retinal Diseases, 5/29/2024 - 2-3pm ET - registration is free
Watch the Video

Upcoming Event

Prevent Blindness Swing fore Sight Golf Tournament, September 18, Bali Hai Golf Club, Las Vegas
Join Us!

Sponsored Content

a patient talking with a healthcare professional

Clinical Research Study

We are sharing an opportunity to participate in a clinical research study being conducted by Janssen Research & Development, LLC.


The purpose of this study is to learn more about the safety and efficacy of an investigational gene therapy for adults with geographic atrophy (GA) caused by age-related macular degeneration (AMD).


The investigational gene therapy is given through a one-time intravitreal injection, which is an injection delivered into the gel-like fluid interior of the eye. This type of injection is a common procedure for people with various eye conditions.


You may be eligible to participate in this study if you:

  • Are 60 years of age or older
  • Have GA caused by AMD


Additional eligibility criteria will apply. Not all individuals with GA may qualify to participate in this study.


If you would like to learn more about this study or to check if you may be eligible to participate, please visit the study site.

PARASOL Geographic Atrophy Study
Janssen Pharmaceuticals

Give the Gift of Sight

PVB-Main-Logo image


Facebook  X  Instagram  LinkedIn  YouTube